The Startup That Wants to Grow You a Backup Body (No Brain Included)

The ultimate plan to live forever is a brand new body.

That’s the pitch from R3 Bio, a small startup that’s been operating under the radar until now. They’ve proposed something that sounds like it crawled out of a Black Mirror script: growing brainless human clones to serve as backup bodies.

I’ve been following Antonio Regalado’s reporting on this over at MIT Technology Review, and the whole thing is equal parts fascinating and unsettling. The idea isn’t entirely new—people have talked about body replacement as a path to immortality for decades—but R3 Bio seems to be the first outfit actually trying to build a business around it.

The technical premise is straightforward enough: take a person’s cells, clone them into an embryo, but genetically engineer that embryo so it never develops a brain. What you’d get is a human-shaped vessel—a body with organs, limbs, and tissue, but no consciousness, no capacity for pain, no sense of self. Just a blank biological shell waiting for its owner’s brain to be transplanted into it.

Easy to say. Hard to do. And ethically, it’s a minefield.

The obvious question: at what point does a clump of human cells become a person? If you grow a clone without a brain, is it just tissue? Or is it a human being that’s been deliberately crippled? The startup’s answer is that without a brain, there’s no personhood. No consciousness means no moral status. It’s just meat.

That logic makes me uncomfortable, and I’m not alone. The bioethics community has already started weighing in, and the reactions range from cautious skepticism to outright horror. Some argue that even a brainless human clone represents a fundamental violation of human dignity—that we’re manufacturing beings of our own kind for the sole purpose of using them as spare parts.

Others point out the practical hurdles. Brain transplantation is still science fiction. We can’t reconnect a spinal cord. We can’t prevent the immune system from rejecting foreign tissue. We can’t keep a brain alive outside a body for more than a few minutes. The gap between having a brainless clone and actually transferring someone’s consciousness into it is enormous.

R3 Bio’s pitch seems to rely on the assumption that these problems will eventually be solved. That’s a big bet on a future that may never arrive. But startups are in the business of big bets, and this one is betting on something that could fundamentally change what it means to be human.

What I find most interesting is the timing. We’re seeing rapid advances in stem cell research, organoid technology, and gene editing. The tools to actually attempt something like this are becoming real. Whether we should use them is a different question.

Regalado’s eBook goes deeper into the company’s origins, the science behind their approach, and the regulatory landscape they’re navigating. It’s subscriber-only content, but if you have access, it’s worth a read. The related stories about replacing the brain piece by piece and the breakthroughs in stem-cell therapies provide useful context.

For now, R3 Bio remains a stealthy operation with a radical vision. Whether they’ll become a footnote in bioethics history or the first step toward a future where death is optional is anyone’s guess. But the conversation they’ve started is one we need to have.